Fundz

Octant Appoints Eddy Anglade, M.D. as Chief Medical Officer

PRIVATENov 17, 2026

Position

Chief Medical Officer

Company

Octant Bio

Eddy Anglade, M.D.

Description

Octant, Inc. has announced the appointment of Dr. Eddy Anglade as its first Chief Medical Officer

Quick answer

Octant Appoints Eddy Anglade, M.D. as Chief Medical Officer (November 17, 2026).

Who is the new Chief Medical Officer at Octant Bio?
Octant Bio named Eddy Anglade, M.D. Chief Medical Officer, announced November 17, 2026.
What did Octant Bio announce on November 17, 2026?
Octant, Inc. has announced the appointment of Dr. Eddy Anglade as its first Chief Medical Officer
What does Octant Bio do?
Octant Bio is a next-generation therapeutics company integrating novel and scaled experimental technologies (multiplexed measurements and high-throughput synthetic chemistry) with computation to solve complex challenges...

Source: Fundz verified event record.

Who to call at Octant Bio, and when

A new leader at Octant Bio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Octant Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Octant Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Octant Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Octant Bio

About

Octant Bio is a next-generation therapeutics company integrating novel and scaled experimental technologies (multiplexed measurements and high-throughput synthetic chemistry) with computation to solve complex challenges in drug discovery. Octant engineers drugs with novel mechanisms of actions guided by extensive proprietary datasets in engineered human cells that unlock insights between genomes, drug candidates, biochemical function, and disease phenotypes. The Octant platform uses synthetic biology, high throughput multiplexed assays, synthetic chemistry, and computation to engineer and interrogate drugs, proteins, and cellular pathways at unprecedented scales. For more information visit www.octant.bio.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Octant Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Octant Bio's next move

Learn about Strategic plan

Octant Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.